Largest health care pharmaceutical companies by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Pfizer leads the 61 health care pharmaceutical companies ranked by net assets, at SAR 324.4B, ahead of Johnson & Johnson (SAR 305.9B) and Sanofi (SAR 297.1B). Figures as of 19 Nov 2026, 14:23 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- PfizerSAR 324.4B
- Median
- SAR 3.3B
- Combined market value
- SAR 18.98T
- Countries
- 10
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | Net assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | SAR 324.4B | SAR 599.9B | SAR 105.25 | 1.44% down | 15% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | SAR 305.9B | SAR 2.46T | SAR 1,022.90 | 2.15% down | 34% up | ||
| 3 | SanofiSNY · Health Care | SAR 297.1B | SAR 424.4B | SAR 176.75 | 0.86% down | 4% down | ||
| 4 | Merck & CoMRK · Health Care | SAR 197.3B | SAR 1.27T | SAR 516.81 | 3.90% down | 45% up | ||
| 5 | Abbott LaboratoriesABT · Health Care | SAR 195.5B | SAR 678.8B | SAR 391.90 | 0.22% down | 16% down | ||
| 6 | AstraZenecaAZN · Health Care | SAR 182.5B | SAR 1.04T | SAR 670.53 | 1.93% down | 1% up | ||
| 7 | Takeda PharmaceuticalTAK · Health Care | SAR 174.5B | SAR 254.9B | SAR 79.78 | 1.71% down | 51% up | ||
| 8 | NovartisNVS · Health Care | SAR 173B | SAR 1.1T | SAR 582.19 | 2.46% down | 25% up | ||
| 9 | Regeneron PharmaceuticalsREGN · Health Care | SAR 117.2B | SAR 366.9B | SAR 3,546.68 | 1.28% down | 28% up | ||
| 10 | Novo NordiskNVO · Health Care | SAR 108B | SAR 651.9B | SAR 147.90 | 3.12% down | 17% down | ||
| 11 | Eli LillyLLY · Health Care | SAR 99.5B | SAR 4.62T | SAR 5,186.70 | 2.32% down | 33% up | ||
| 12 | GSKGSK · Health Care | SAR 81.5B | SAR 365.3B | SAR 182.22 | 1.34% down | 5% up | ||
| 13 | Vertex PharmaceuticalsVRTX · Health Care | SAR 70B | SAR 510.2B | SAR 2,012.22 | 0.42% up | 27% up | ||
| 14 | Bristol-Myers SquibbBMY · Health Care | SAR 69.3B | SAR 456.7B | SAR 223.41 | 2.92% down | 30% up | ||
| 15 | ViatrisVTRS · Health Care | SAR 55.2B | SAR 87.2B | SAR 76.07 | 0.83% down | 99% up | ||
| 16 | Royalty PharmaRPRX · Health Care | SAR 36.4B | SAR 148.1B | SAR 257.58 | 0.01% down | 79% up | ||
| 17 | Teva Pharmaceutical IndustriesTEVA · Health Care | SAR 29.7B | SAR 184.8B | SAR 158.40 | 0.92% down | 74% up | ||
| 18 | United TherapeuticsUTHR · Health Care | SAR 26.6B | SAR 92.2B | SAR 2,165.60 | 1.16% down | 22% up | ||
| 19 | Elanco Animal HealthELAN · Health Care | SAR 24.6B | SAR 50.1B | SAR 100.15 | 3.29% up | 26% up | ||
| 20 | BioMarin PharmaceuticalBMRN · Health Care | SAR 22.8B | SAR 44.6B | SAR 230.42 | 4.99% up | 17% up | ||
| 21 | GrifolsGRFS · Health Care | SAR 21.9B | SAR 21.6B | SAR 31.77 | 1.85% down | 0% up | ||
| 22 | GenmabGMAB · Health Care | SAR 21.9B | SAR 117.9B | SAR 191.19 | 1.91% down | 70% up | ||
| 23 | Roivant SciencesROIV · Health Care | SAR 17B | SAR 105.3B | SAR 145.28 | 0.05% up | 91% up | ||
| 24 | BeOne MedicinesONC · Health Care | SAR 16.4B | SAR 172.9B | SAR 1,513.90 | 2.34% down | 16% up | ||
| 25 | Jazz PharmaceuticalsJAZZ · Health Care | SAR 16.2B | SAR 59.7B | SAR 929.39 | 2.93% up | 41% up | ||
| 26 | Dr. Reddy's LaboratoriesRDY · Health Care | SAR 15B | SAR 46.8B | SAR 56.19 | 1.28% up | 8% up | ||
| 27 | ZoetisZTS · Health Care | SAR 12.5B | SAR 130.4B | SAR 320.97 | 2.50% up | 26% down | ||
| 28 | AlkermesALKS · Health Care | SAR 6.8B | SAR 29.5B | SAR 175.73 | 3.08% up | 66% up | ||
| 29 | Ligand PharmaceuticalsLGND · Health Care | SAR 3.8B | SAR 22.4B | SAR 1,120.46 | 1.67% up | 50% up | ||
| 30 | Legend BiotechLEGN · Health Care | SAR 3.8B | SAR 11.8B | SAR 60.95 | 0.87% up | 41% down | ||
| 31 | Praxis Precision MedicinesPRAX · Health Care | SAR 3.3B | SAR 32B | SAR 1,144.77 | 0.04% up | 86% up | ||
| 32 | Alnylam PharmaceuticalsALNY · Health Care | SAR 3B | SAR 75.1B | SAR 560.40 | 4.54% down | 66% down | ||
| 33 | Belite BioBLTE · Health Care | SAR 2.9B | SAR 23.8B | SAR 586.02 | 0.94% down | 43% up | ||
| 34 | InsmedINSM · Health Care | SAR 2.8B | SAR 98.6B | SAR 449.37 | 1.69% down | 40% down | ||
| 35 | Spyre TherapeuticsSYRE · Health Care | SAR 2.7B | SAR 36.1B | SAR 380.58 | 8.15% up | 332% up | ||
| 36 | Summit TherapeuticsSMMT · Health Care | SAR 2.5B | SAR 31.5B | SAR 39.39 | 1.59% down | 36% down | ||
| 37 | TG TherapeuticsTGTX · Health Care | SAR 2.4B | SAR 37.5B | SAR 248.02 | 5.44% up | 117% up | ||
| 38 | Corcept TherapeuticsCORT · Health Care | SAR 2.4B | SAR 27.8B | SAR 254.28 | 3.25% down | 10% down | ||
| 39 | Cogent BiosciencesCOGT · Health Care | SAR 2.4B | SAR 18.2B | SAR 104.32 | 0.14% down | 20% down | ||
| 40 | Protagonist TherapeuticsPTGX · Health Care | SAR 2.3B | SAR 31.1B | SAR 476.98 | 2.00% up | 51% up | ||
| 41 | Madrigal PharmaceuticalsMDGL · Health Care | SAR 2.3B | SAR 34.7B | SAR 1,493.20 | 5.67% down | 27% down | ||
| 42 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SAR 2.1B | SAR 28B | SAR 356.53 | 0.06% down | 129% up | ||
| 43 | Edgewise TherapeuticsEWTX · Health Care | SAR 2B | SAR 17B | SAR 155.18 | 1.59% down | 86% up | ||
| 44 | ABIVAXABVX · Health Care | SAR 1.9B | SAR 27.5B | SAR 314.45 | 2.11% up | 32% down | ||
| 45 | Dianthus TherapeuticsDNTH · Health Care | SAR 1.9B | SAR 17.7B | SAR 315.01 | 3.45% down | 108% up | ||
| 46 | Ionis PharmaceuticalsIONS · Health Care | SAR 1.8B | SAR 17.1B | SAR 102.74 | 1.59% up | 63% down | ||
| 47 | Oruka TherapeuticsORKA · Health Care | SAR 1.8B | SAR 24.4B | SAR 359.12 | 0.60% down | 255% up | ||
| 48 | Arrowhead PharmaceuticalsARWR · Health Care | SAR 1.7B | SAR 22.9B | SAR 161.71 | 0.28% up | 13% up | ||
| 49 | Definium TherapeuticsDFTX · Health Care | SAR 1.2B | SAR 15B | SAR 109.23 | 0.88% down | 168% up | ||
| 50 | ErascaERAS · Health Care | SAR 1.2B | SAR 18.1B | SAR 51.61 | 0.94% down | 395% up | ||
| 51 | Mirum PharmaceuticalsMIRM · Health Care | SAR 1.2B | SAR 22.6B | SAR 346.93 | 0.59% up | 34% up | ||
| 52 | Rhythm PharmaceuticalsRYTM · Health Care | SAR 521.6M | SAR 31B | SAR 446.52 | 2.08% up | 18% up | ||
| 53 | Travere TherapeuticsTVTX · Health Care | SAR 430.7M | SAR 18.1B | SAR 188.45 | 1.68% down | 45% up | ||
| 54 | Axsome TherapeuticsAXSM · Health Care | SAR 331.2M | SAR 26.4B | SAR 502.63 | 1.43% down | 6% down | ||
| 55 | Amneal PharmaceuticalsAMRX · Health Care | -SAR 265.5M | SAR 28.6B | SAR 82.07 | 3.60% up | 90% up | ||
| 56 | VeradermicsMANE · Health Care | -SAR 453.9M | SAR 19.8B | SAR 468.35 | 0.62% down | 231% up | ||
| 57 | Ascendis PharmaASND · Health Care | -SAR 677.6M | SAR 66.5B | SAR 1,014.01 | 0.32% down | 29% up | ||
| 58 | PTC TherapeuticsPTCT · Health Care | -SAR 770.1M | SAR 18.9B | SAR 225.92 | 0.22% down | 21% down | ||
| 59 | CytokineticsCYTK · Health Care | -SAR 2.5B | SAR 26.8B | SAR 192.50 | 0.64% down | 19% down | ||
| 60 | BridgeBio PharmaBBIO · Health Care | -SAR 7.8B | SAR 57B | SAR 292.62 | 1.58% up | 21% up | ||
| 61 | AbbVieABBV · Health Care | -SAR 12.3B | SAR 1.9T | SAR 1,072.82 | 2.33% down | 25% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR).
Questions and answers
Which health care pharmaceutical companies rank first by net assets?
Pfizer (SAR 324.4B), Johnson & Johnson (SAR 305.9B) and Sanofi (SAR 297.1B) are the top three of the 61 health care pharmaceutical companies ranked by net assets as of 19 Nov 2026, 14:23 UTC.
How many health care pharmaceutical companies are in this ranking?
61 are ranked by net assets.
What are these health care pharmaceutical companies worth together?
The 61 health care pharmaceutical companies ranked by net assets have a combined market value of SAR 18.98T as of 19 Nov 2026, 14:23 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care pharmaceutical companies by net assets”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.